Last reviewed · How we verify

Dropless Regimen — Competitive Intelligence Brief

Dropless Regimen (Dropless Regimen) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Anti-inflammatory combination regimen. Area: Ophthalmology.

marketed Anti-inflammatory combination regimen Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

Dropless Regimen (Dropless Regimen) — University of California, San Francisco. A perioperative anti-inflammatory regimen that eliminates the need for postoperative topical corticosteroid and nonsteroidal anti-inflammatory eye drops following cataract surgery.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Dropless Regimen TARGET Dropless Regimen University of California, San Francisco marketed Anti-inflammatory combination regimen

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Anti-inflammatory combination regimen class)

  1. University of California, San Francisco · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Dropless Regimen — Competitive Intelligence Brief. https://druglandscape.com/ci/dropless-regimen. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: